Tier C — preclinical

Ipamorelin

Selective growth-hormone secretagogue; ghrelin receptor (GHS-R1a) agonist.

Conceptual chain illustration for Ipamorelin — for representation purposes only. Not the compound's verified molecular structure.

Evidence

Preclinical, plus limited early human pharmacology. No approval.

Comparatively selective — stimulates GH release with less effect on cortisol and prolactin than older GHRPs, per the available pharmacology data.

Looking for this product?